Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hemamali Samaratunga

Showing results (101-110 of 187) with videos related to

Pageof 19
Sort By:
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 24, 2023
Web-grading-a tool to test personal grading of renal and prostate cancerGlen Kristiansen, Matthias Schmid, Lars Egevad, et al.
Pathology|December 5, 2013
Clinical significance of cancer in radical prostatectomy specimens: analysis from a contemporary series of 2900 menHemamali Samaratunga, Brett Delahunt, John Yaxley, et al.
Pathology|January 2, 2021
Prognostic significance of morphological patterns of Gleason grade 5 prostatic adenocarcinoma diagnosed on needle biopsyAnthony Franklin, Brett Delahunt, Lars Egevad, et al.
Pathology|June 1, 2025
High proportion of clinically significant prostate adenocarcinomas in radical cystoprostatectomy specimens following complete prostate samplingBrett Delahunt, Shulammite Johannsen, Lars Egevad, et al.
BJU International|August 16, 2016
Consensus guidelines for reporting prostate cancer Gleason GradeLars Egevad, Hemamali Samaratunga, John R Srigley, et al.
The American Journal of Surgical Pathology|June 29, 2023
International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial CarcinomasGladell P Paner, Ashish Kamat, George J Netto, et al.
The American Journal of Surgical Pathology|July 1, 2011
Grading of clear cell renal cell carcinoma should be based on nucleolar prominenceBrett Delahunt, Dianne Sika-Paotonu, Peter B Bethwaite, et al.
International Journal of Cancer|December 21, 2004
Use of multiple biomarkers for a molecular diagnosis of prostate cancerKelly A Landers, Michelle J Burger, Michelle A Tebay, et al.
Virchows Archiv : an International Journal of Pathology|February 3, 2021
Interobserver reproducibility of perineural invasion of prostatic adenocarcinoma in needle biopsiesLars Egevad, Brett Delahunt, Hemamali Samaratunga, et al.
Pathology|December 9, 2023
Gleason score 3+3=6 prostatic adenocarcinoma is not benign and the current debate is unhelpful to clinicians and patientsHemamali Samaratunga, Lars Egevad, John Yaxley, et al.
Pageof 19

Showing results (101-110 of 187) with videos related to

Sort By:
Pageof 19
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 24, 2023
Web-grading-a tool to test personal grading of renal and prostate cancerGlen Kristiansen, Matthias Schmid, Lars Egevad, et al.
Pathology|December 5, 2013
Clinical significance of cancer in radical prostatectomy specimens: analysis from a contemporary series of 2900 menHemamali Samaratunga, Brett Delahunt, John Yaxley, et al.
Pathology|January 2, 2021
Prognostic significance of morphological patterns of Gleason grade 5 prostatic adenocarcinoma diagnosed on needle biopsyAnthony Franklin, Brett Delahunt, Lars Egevad, et al.
Pathology|June 1, 2025
High proportion of clinically significant prostate adenocarcinomas in radical cystoprostatectomy specimens following complete prostate samplingBrett Delahunt, Shulammite Johannsen, Lars Egevad, et al.
BJU International|August 16, 2016
Consensus guidelines for reporting prostate cancer Gleason GradeLars Egevad, Hemamali Samaratunga, John R Srigley, et al.
The American Journal of Surgical Pathology|June 29, 2023
International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial CarcinomasGladell P Paner, Ashish Kamat, George J Netto, et al.
The American Journal of Surgical Pathology|July 1, 2011
Grading of clear cell renal cell carcinoma should be based on nucleolar prominenceBrett Delahunt, Dianne Sika-Paotonu, Peter B Bethwaite, et al.
International Journal of Cancer|December 21, 2004
Use of multiple biomarkers for a molecular diagnosis of prostate cancerKelly A Landers, Michelle J Burger, Michelle A Tebay, et al.
Virchows Archiv : an International Journal of Pathology|February 3, 2021
Interobserver reproducibility of perineural invasion of prostatic adenocarcinoma in needle biopsiesLars Egevad, Brett Delahunt, Hemamali Samaratunga, et al.
Pathology|December 9, 2023
Gleason score 3+3=6 prostatic adenocarcinoma is not benign and the current debate is unhelpful to clinicians and patientsHemamali Samaratunga, Lars Egevad, John Yaxley, et al.
Pageof 19